← Back to guidelines
Pathology29 papers

Mucoepidermoid carcinoma of salivary gland

Last edited: 4/14/2026

Overview

Mucoepidermoid carcinoma (MEC) is the most common malignant neoplasm arising from salivary glands, characterized by a mixed population of mucus-secreting, epidermoid, and intermediate cells 3.

Diagnosis

  • Fine Needle Aspiration (FNA): Essential for preoperative evaluation; expert cytopathologists achieve high accuracy in grading (89.4% overall) 1.
  • Histopathologic Grading: Critical for clinical management; low-grade (90.2% accuracy) and high-grade (88.3% accuracy) differentiation is feasible 1.
  • Immunohistochemistry: Carcinoembryonic antigen (CEA) can be a useful marker, particularly positive in mucoepidermoid carcinoma (100% in studied cases) 4.
  • Management

  • Primary Treatment: Surgical resection is typically the first-line approach, often followed by adjuvant radiotherapy for high-grade tumors 3.
  • Radiotherapy: Used adjunctively, especially in high-grade cases or for residual disease post-surgery 23.
  • Abscopal Effect: Rare instances of abscopal response observed without systemic therapy, suggesting potential for radiotherapy alone in select cases 2.
  • Special Populations

  • Elderly Patients: Management strategies may need adjustment due to comorbidities; individualized treatment plans are crucial 2.
  • Key Recommendations

  • Utilize fine needle aspiration with expert cytopathologists for accurate preoperative grading of salivary gland carcinomas (Evidence: Strong 1).
  • Surgical resection should be considered the primary treatment modality for mucoepidermoid carcinoma, with adjuvant radiotherapy recommended for high-grade tumors (Evidence: Moderate 3).
  • Consider the potential for abscopal effects in elderly patients undergoing radiotherapy, though evidence is derived from case reports (Evidence: Weak 2).
  • References

    1 Johnson DN, Onenerk M, Krane JF, Rossi ED, Baloch Z, Barkan G et al.. Cytologic grading of primary malignant salivary gland tumors: A blinded review by an international panel. Cancer cytopathology 2020. link 2 Ellerin BE, Demandante CGN, Martins JT. Pure abscopal effect of radiotherapy in a salivary gland carcinoma: Case report, literature review, and a search for new approaches. Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique 2020. link 3 Seethala RR, Altemani A, Ferris RL, Fonseca I, Gnepp DR, Ha P et al.. Data Set for the Reporting of Carcinomas of the Major Salivary Glands: Explanations and Recommendations of the Guidelines From the International Collaboration on Cancer Reporting. Archives of pathology & laboratory medicine 2019. link 4 Takahashi H, Tsuda N, Tezuka F, Okabe H. Immunohistochemical localization of carcinoembryonic antigen in carcinoma in pleomorphic adenoma of salivary gland: use in the diagnosis of benign and malignant lesions. The Tohoku journal of experimental medicine 1986. link

    Original source

    1. [1]
      Cytologic grading of primary malignant salivary gland tumors: A blinded review by an international panel.Johnson DN, Onenerk M, Krane JF, Rossi ED, Baloch Z, Barkan G et al. Cancer cytopathology (2020)
    2. [2]
      Pure abscopal effect of radiotherapy in a salivary gland carcinoma: Case report, literature review, and a search for new approaches.Ellerin BE, Demandante CGN, Martins JT Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique (2020)
    3. [3]
      Data Set for the Reporting of Carcinomas of the Major Salivary Glands: Explanations and Recommendations of the Guidelines From the International Collaboration on Cancer Reporting.Seethala RR, Altemani A, Ferris RL, Fonseca I, Gnepp DR, Ha P et al. Archives of pathology & laboratory medicine (2019)
    4. [4]

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG